# Cellect Biotechnology Ltd. (APOP)

Source: https://www.quantisnow.com/company/APOP
Generated: 2026-11-11T03:13:22.780Z

- Ticker: APOP
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- IPO year: 2016
- Website: cellect.co

## About

Cellect Biotechnology Ltd., a biotechnology company, engages in developing ApoGraft, a technology platform that functionally selects stem cells to enhance the safety of regenerative medicine and stem cell therapies in Israel. The company develops ApoTainer, a kit for hematopoietic stem cell transplantation procedures. It has collaborations with the denovoMATRIX group of the Technische Universität Dresden to conduct examinations into the tentative synergy between ApoGraft and denovoMAtrix technology for the purpose of evaluating collaborative development of products for regenerative medicine; Cell2in Inc. to conduct scientific evaluations combining ApoGraft with Cell2in's identification technology FreSHtracer, which monitors stem cell quality by utilizing a fluorescent dye to characterize their oxidative stress state; and XNK therapeutics to focus on the development of cell-based therapeutics from NK cells. The company was formerly known as Cellect Biomed Ltd. and changed its name to Cellect Biotechnology Ltd. in July 2016. Cellect Biotechnology Ltd. was incorporated in 1986 and is headquartered in Kfar Saba, Israel.

## Latest APOP news and filings

- 2021-12-18 00:47 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cellect Biotechnology Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cellect-biotechnology-ltd-2161596)
- 2021-11-23 22:07 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cellect Biotechnology Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cellect-biotechnology-ltd-2049139)
- 2021-11-12 19:20 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Cellect Biotechnology Ltd.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-cellect-biotechnology-ltd-2001993)
- 2021-10-29 13:31 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cellect Biotechnology Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cellect-biotechnology-ltd-1933021)
- 2021-10-15 20:06 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cellect Biotechnology Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cellect-biotechnology-ltd-1880530)
- 2021-10-15 20:01 UTC [Cellect Biotechnology Announces Record Date and Distribution Date for CVRs in Connection with Strategic Merger with Quoin Pharmaceuticals](https://www.quantisnow.com/insight/cellect-biotechnology-announces-record-date-and-distribution-date-for-cvrs-1880451)
- 2021-09-27 13:14 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cellect Biotechnology Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cellect-biotechnology-ltd-1811457)
- 2021-09-27 13:10 UTC [Cellect Biotechnology Announces Shareholder Approval of Strategic Merger with Quoin Pharmaceuticals](https://www.quantisnow.com/insight/cellect-biotechnology-announces-shareholder-approval-of-strategic-merger-with-quoin-1811438)
- 2021-09-20 20:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cellect Biotechnology Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cellect-biotechnology-ltd-1789798)
- 2021-09-17 21:30 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cellect Biotechnology Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cellect-biotechnology-ltd-1785664)
- 2021-09-10 12:52 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cellect Biotechnology Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cellect-biotechnology-ltd-1759652)
- 2021-09-02 20:33 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cellect Biotechnology Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cellect-biotechnology-ltd-1737490)
- 2021-09-02 20:20 UTC [Cellect Biotechnology Announces the ApoGraft™ Bone Marrow Transplantation of First Patient in U.S.](https://www.quantisnow.com/insight/cellect-biotechnology-announces-the-apograft-bone-marrow-transplantation-of-first-1737298)
- 2021-08-24 20:26 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cellect Biotechnology Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cellect-biotechnology-ltd-1703777)
- 2021-08-24 20:16 UTC [Cellect Biotechnology Reports Second Quarter 2021 Financial and Operating Results](https://www.quantisnow.com/insight/cellect-biotechnology-reports-second-quarter-2021-financial-and-operating-results-1703690)
- 2021-08-13 21:21 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cellect Biotechnology Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cellect-biotechnology-ltd-1669131)
- 2021-08-13 20:20 UTC [The Securities and Exchange Commission Declared Cellect Biotechnology's Registration Statement Filed on Form F-4 Effective in Connection with its Previously Announced Strategic Merger with Quoin Pharmaceuticals](https://www.quantisnow.com/insight/the-securities-and-exchange-commission-declared-cellect-biotechnologys-registration-statement-1668597)
- 2021-08-13 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Cellect Biotechnology Ltd.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-cellect-biotechnology-ltd-1665810)
- 2021-08-10 19:22 UTC [SEC Form F-4/A filed by Cellect Biotechnology Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-f-4a-filed-by-cellect-biotechnology-ltd-amendment-1651159)
- 2021-08-06 01:24 UTC [SEC Form F-4/A filed by Cellect Biotechnology Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-f-4a-filed-by-cellect-biotechnology-ltd-amendment-1635614)
- 2021-07-16 20:09 UTC [SEC Form F-4/A filed by Cellect Biotechnology Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-f-4a-filed-by-cellect-biotechnology-ltd-amendment-1399008)
- 2021-06-16 22:58 UTC [Cellect Biotechnology Files Registration Statement in Connection with Proposed Strategic Merger Agreement with Quoin Pharmaceuticals](https://www.quantisnow.com/insight/cellect-biotechnology-files-registration-statement-in-connection-with-proposed-strategic-1043202)
- 2021-06-16 20:40 UTC [SEC Form F-4 filed by Cellect Biotechnology Ltd.](https://www.quantisnow.com/insight/sec-form-f-4-filed-by-cellect-biotechnology-ltd-1040897)
- 2021-06-03 20:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cellect Biotechnology Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cellect-biotechnology-ltd-957336)
- 2021-04-19 12:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cellect Biotechnology Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cellect-biotechnology-ltd-627773)
- 2021-04-19 12:00 UTC [Cellect Biotechnology Reports Top Line Data from Phase 1/2 Clinical Trial](https://www.quantisnow.com/insight/cellect-biotechnology-reports-top-line-data-from-phase-12-clinical-627571)
- 2021-03-29 13:31 UTC [SEC Form 20-F filed by Cellect Biotechnology Ltd.](https://www.quantisnow.com/insight/sec-form-20-f-filed-by-cellect-biotechnology-ltd-560738)
- 2021-03-29 13:29 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cellect Biotechnology Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cellect-biotechnology-ltd-560691)
- 2021-03-24 21:27 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cellect Biotechnology Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cellect-biotechnology-ltd-549964)
- 2021-03-24 21:26 UTC [Cellect Biotechnology and Quoin Pharmaceuticals Announce Strategic Merger](https://www.quantisnow.com/insight/cellect-biotechnology-and-quoin-pharmaceuticals-announce-strategic-merger-549951)
- 2021-02-16 14:42 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-398227)
- 2021-02-11 16:52 UTC [SEC Form 6-K/A filed](https://www.quantisnow.com/insight/sec-form-6-ka-filed-383298)
- 2021-01-13 14:03 UTC [SEC Form SC 13G filed](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-280961)
- 2020-11-20 13:00 UTC [Cellect Biotechnology Reports Third Quarter Financial and Operating Results; Recent Developments Position Company to Accelerate Progress in 2021](https://www.quantisnow.com/insight/cellect-biotechnology-reports-third-quarter-financial-and-operating-results-recent-172150)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/APOP
- Earnings history: https://www.quantisnow.com/earnings/APOP
- Dividend history: https://www.quantisnow.com/dividends/APOP
- Insider transactions: https://www.quantisnow.com/insiders/APOP
- Options chain: https://www.quantisnow.com/options/APOP
- SEC 8-K filings only: https://www.quantisnow.com/company/APOP/8-k
- RSS and alerts for APOP: https://www.quantisnow.com/docs/rss-feeds.md